Key statistics
On Friday, Perspective Therapeutics Inc (AAJ0:MUN) closed at 11.60, -32.56% below its 52-week high of 17.20, set on May 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | 11.60 |
Low | 11.60 |
Bid | -- |
Offer | -- |
Previous close | 11.60 |
Average volume | -- |
---|---|
Shares outstanding | 67.43m |
Free float | 53.66m |
P/E (TTM) | -- |
Market cap | 892.07m USD |
EPS (TTM) | -1.39 USD |
Data delayed at least 15 minutes, as of Jun 14 2024 07:04 BST.
More ▼
Announcements
- Perspective Therapeutics Presents at the World Molecular Imaging Congress 2024
- Perspective Therapeutics Granted Fast Track Designation for VMT01 for the Diagnosis and Treatment of MC1R-Positive Melanoma
- Perspective Therapeutics to Participate in Upcoming Investor Conferences in September
- Perspective Therapeutics to Participate at Upcoming Investor Conferences in August
- Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2024 Financial Results
- Perspective Therapeutics Announces Inclusion in the Russell 3000® Index
- Perspective Therapeutics Announces 1-for-10 Reverse Stock Split
- Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting
- Perspective Therapeutics Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
- Perspective Therapeutics to Participate at Upcoming May Investor Conferences
More ▼